Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
Wenxing Gu, Fenghua Meng, Rainer Haag, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 676-695
Closed Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Functionalized liposomes for targeted breast cancer drug delivery
Janske Nel, Kamil Elkhoury, Émilie Velot, et al.
Bioactive Materials (2023) Vol. 24, pp. 401-437
Open Access | Times Cited: 91
Recent advances in drug delivery systems for targeting brain tumors
Yi Zhao, Ping Yue, Yao Peng, et al.
Drug Delivery (2023) Vol. 30, Iss. 1, pp. 1-18
Open Access | Times Cited: 40
Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer
Xueli Tian, Tingxuan Gu, Mee‐Hyun Lee, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188645-188645
Closed Access | Times Cited: 79
Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
Xinyun Qiu, Yan Qu, Beibei Guo, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 498-510
Closed Access | Times Cited: 69
Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications
Daniel Braatz, Mariam Cherri, Michael Tully, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 49
Open Access | Times Cited: 50
Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics
Zhaoyu Ma, Heyou Han, Yanli Zhao
Biomaterials (2022) Vol. 293, pp. 121947-121947
Open Access | Times Cited: 42
ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy
Jingjing Wei, Di Wu, Yu Shao, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 68-77
Closed Access | Times Cited: 35
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 27
Photoactivated DNA Nanodrugs Damage Mitochondria to Improve Gene Therapy for Reversing Chemoresistance
Danyu Wang, Yi Hua, Shizhen Geng, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16923-16934
Closed Access | Times Cited: 20
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 8
Rationalized landscape on protein-based cancer nanomedicine: Recent progress and challenges
Zhechen Fan, Haroon Iqbal, Ni Jiang, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100238-100238
Open Access | Times Cited: 8
Bioinspired Tumor Calcification‐Guided Early Diagnosis and Eradication of Hepatocellular Carcinoma
Shuang Bai, Hu Chen, Shiying Fu, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 7
Strategic Developments in Polymer-Functionalized Liposomes for Targeted Colon Cancer Therapy: An Updated Review of Clinical Trial Data and Future Horizons
Satyam Sharma, Moitrai Chakraborty, Dharmendra Yadav, et al.
Biomacromolecules (2024) Vol. 25, Iss. 9, pp. 5650-5669
Closed Access | Times Cited: 6
Synthesis of Gold Nanoparticles Using Extracts or Biomolecules Contained in Pecan Nut for Potential Applications in the Treatment of Acute Lymphoblastic Leukemia
José Guzmán Mendoza, German Hoyos Conteras, A. Castillo, et al.
IFMBE proceedings (2025), pp. 179-186
Closed Access
Optimizing Surface Maleimide/cRGD Ratios Enhances Targeting Efficiency of cRGD-Functionalized Nanomedicines
Rundi Song, Jiajia Tan, Jie Cen, et al.
Journal of the American Chemical Society (2025)
Closed Access
Emerging targeted drug delivery strategies toward ovarian cancer
Zhe Wang, Fenghua Meng, Zhiyuan Zhong
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113969-113969
Closed Access | Times Cited: 51
3D Printing in Development of Nanomedicines
Keerti Jain, Rahul Shukla, Awesh K. Yadav, et al.
Nanomaterials (2021) Vol. 11, Iss. 2, pp. 420-420
Open Access | Times Cited: 50
Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo
Yaohua Wei, Yinping Sun, Jingjing Wei, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 521-529
Open Access | Times Cited: 46
Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel
Xiuxiu Wang, Ru Cheng, Zhiyuan Zhong
Acta Biomaterialia (2021) Vol. 125, pp. 280-289
Closed Access | Times Cited: 43
Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy
Jaehyun Kim, Juhyeong Hong, Jieun Lee, et al.
Journal of Controlled Release (2021) Vol. 332, pp. 109-126
Closed Access | Times Cited: 41
“Targeting Design” of Nanoparticles in Tumor Therapy
Tingting Yang, Jingming Zhai, Dong Hu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1919-1919
Open Access | Times Cited: 34
Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release
Avelino Corma, Pablo Botella, Eva Rivero‐Buceta
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 110-110
Open Access | Times Cited: 31
Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer
Solmaz Mojarad-Jabali, Somayeh Mahdinloo, Masoud Farshbaf, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 6, pp. 685-705
Closed Access | Times Cited: 30
Progress and challenges in the translation of cancer nanomedicines
Fan Tong, Yufan Wang, Huile Gao
Current Opinion in Biotechnology (2023) Vol. 85, pp. 103045-103045
Closed Access | Times Cited: 17
The Dawn of a New Era: Tumor-Targeting Boron Agents for Neutron Capture Therapy
Ting Luo, Wenzhi Huang, Feiyi Chu, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 10, pp. 4942-4970
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top